Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Detection of dysplastic colorectal polyps during colonoscopy after EMI-137 injection
2016-002827-27Phase 2Terminated
- Sponsor
- Edinburgh Molecular Imaging
- Start
- Oct 2016
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of emi-137 in colonic polyp and colorectal neoplasm, sponsored by Edinburgh Molecular Imaging. Primary endpoint: Efficacy. Started Oct 2016; status: terminated.
02
Drugs
emi-137
03
Conditions
colonic polypcolorectal neoplasm
Beyond the preview
Go deeper on 2016-002827-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002827-27.